mRNA aggregates harness danger response for potent cancer immunotherapy. - Mendez-Gomez HR; DeVries A; Castillo P; Stover BD; Qdaisat S; Von Roemeling C; Ogando-Rivas E; Weidert F; McGuiness J; Zhang D; Chung MC; Li D; et al. (MedRxiv : the preprint server for health sciences, 2023)